Clinical Trial

A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases

Name: A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases — clinical trial record (NCT07357220)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

An open-label, multicenter, phase Ib/II study of AK112 in combination with VG2025 for advanced colorectal cancer with liver metastases.

Trial Details

NCT Number	NCT07357220
Lead Sponsor	Akeso Collaborators: Shanghai Virogin Biotech Co., Ltd.
Conditions	Colorectal Cancer With Hepatic Metastases
Enrollment	72 participants
Start Date	2026-03-02
Primary Completion	2027-02-28 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-01-21